Cargando…
Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants
BACKGROUND: Disclosure of pathogenic variants to thoracic aortic dissection biobank participants was implemented. The impact and costs, including confirmatory genetic testing in a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory, were evaluated. METHODS: We exome sequenced 240...
Autores principales: | Beil, Adelyn, Hornsby, Whitney, Uhlmann, Wendy R., Aatre, Rajani, Arscott, Patricia, Wolford, Brooke, Eagle, Kim A., Yang, Bo, McNamara, Jennifer, Willer, Cristen, Roberts, J. Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923508/ https://www.ncbi.nlm.nih.gov/pubmed/33648514 http://dx.doi.org/10.1186/s12920-021-00902-5 |
Ejemplares similares
-
Your Biobank, Your Doctor?: The right to full disclosure of population biobank findings
por: Bovenberg, J. A., et al.
Publicado: (2009) -
Incorporating family disease history and controlling case–control imbalance for population-based genetic association studies
por: Zhuang, Yongwen, et al.
Publicado: (2022) -
Funding considerations for the disclosure of genetic incidental findings in biobank research
por: Black, L, et al.
Publicado: (2013) -
An audit on consent- risk disclosure in thoracic surgery
por: Prasher, Sparsh, et al.
Publicado: (2015) -
eP217: Ophthalmology genetics clinic in the times of COVID-19: A hybrid model
por: Pritchard, Amanda, et al.
Publicado: (2022)